{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:09:59Z","timestamp":1791083399411,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,8,11]],"date-time":"2006-08-11T00:00:00Z","timestamp":1155254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s11095-006-9054-x","type":"journal-article","created":{"date-parts":[[2006,8,10]],"date-time":"2006-08-10T15:08:51Z","timestamp":1155222531000},"page":"2165-2174","source":"Crossref","is-referenced-by-count":168,"title":["Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats"],"prefix":"10.1007","volume":"23","author":[{"given":"Arik","family":"Dahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnon","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,11]]},"reference":[{"key":"9054_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"C. A. Lipinski","year":"2001","unstructured":"C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46:3\u201326 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9054_CR2","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","volume":"11","author":"C. W. Pouton","year":"2000","unstructured":"C. W. Pouton. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur. J. Pharm Sci. 11:S93\u2013S98 (2000).","journal-title":"Eur. J. Pharm Sci."},{"key":"9054_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-409X(96)00494-2","volume":"25","author":"A. J. Humberstone","year":"1997","unstructured":"A. J. Humberstone, and W. N. Charman. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 25:103\u2013128 (1997).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9054_CR4","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1023\/A:1015000503629","volume":"16","author":"J. M. Dintaman","year":"1999","unstructured":"J. M. Dintaman, and J. A. Silverman. Inhibition of P-glycoprotein by d-\u00e1-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res. 16:1550\u20131556 (1999).","journal-title":"Pharm Res."},{"key":"9054_CR5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","volume":"12","author":"G. L. Amidon","year":"1995","unstructured":"G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413\u2013420 (1995).","journal-title":"Pharm Res."},{"key":"9054_CR6","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/S0169-409X(01)00182-X","volume":"50","author":"C. J. H. Porter","year":"2001","unstructured":"C. J. H. Porter, and W. N. Charman. In vitro assessment of oral lipid based formulations. Adv. Drug Deliv. Rev. 50:S127\u2013S147 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9054_CR7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejps.2004.08.003","volume":"23","author":"J. O. Christensen","year":"2004","unstructured":"J. O. Christensen, K. Schultz, B. Mollgaard, H. G. Kristensen, and A. Mullertz. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur. J. Pharm Sci. 23:287\u2013296 (2004).","journal-title":"Eur. J. Pharm Sci."},{"key":"9054_CR8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jps.10329","volume":"92","author":"G. A. Kossena","year":"2003","unstructured":"G. A. Kossena, B. J. Boyd, Christopher J. H. Porter, and W. N. Charman. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J. Pharm Sci. 92:634\u2013648 (2003).","journal-title":"J. Pharm Sci."},{"key":"9054_CR9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2005.02.038","volume":"298","author":"H. Ljusberg-Wahren","year":"2005","unstructured":"H. Ljusberg-Wahren, F. Seier Nielsen, M. Brogard, E. Troedsson, and A. Mullertz. Enzymatic characterization of lipid-based drug delivery systems. Int. J. Pharm 298:328\u2013332 (2005).","journal-title":"Int. J. Pharm"},{"key":"9054_CR10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/0022-4731(80)90053-9","volume":"13","author":"W. Nienstedt","year":"1980","unstructured":"W. Nienstedt, A. Ojanotko, and H. Toivonen. Metabolism of progesterone, 17-hydroxyprogesterone and deoxycorticosterone by human small intestine in vitro. J. Steroid Biochem. 13:1417\u20131420 (1980).","journal-title":"J. Steroid Biochem."},{"key":"9054_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/00365521.1970.12096613","volume":"5","author":"M. P. Harri","year":"1970","unstructured":"M. P. Harri, W. Nienstedt, and K. Hartiala. Steroid metabolism by the canine intestine. II. The metabolism of progesterone by the jejunal mucosa in vitro. Scand J. Gastroenterol 5:415\u2013419 (1970).","journal-title":"Scand J. Gastroenterol"},{"key":"9054_CR12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejps.2004.12.006","volume":"24","author":"A. Dahan","year":"2005","unstructured":"A. Dahan, and A. Hoffman. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur. J. Pharm Sci. 24:381\u2013388 (2005).","journal-title":"Eur. J. Pharm Sci."},{"key":"9054_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1211\/0022357021771896","volume":"54","author":"L. Sek","year":"2002","unstructured":"L. Sek, C. J. Porter, A. M. Kaukonen, and W. N. Charman. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J. Pharm Pharmacol 54:29\u201341 (2002).","journal-title":"J. Pharm Pharmacol"},{"key":"9054_CR14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0731-7085(00)00528-8","volume":"25","author":"L. Sek","year":"2001","unstructured":"L. Sek, C. J. H. Porter, and W. N. Charman. Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. J. Pharml. Biomed. Anal. 25:651\u2013661 (2001).","journal-title":"J. Pharml Biomed. Anal"},{"key":"9054_CR15","first-page":"117","volume":"249","author":"A. Hoffman","year":"1989","unstructured":"A. Hoffman, and G. Levy. Kinetics of drug action in disease states. XXIX. Effect of experimental nephrotic syndrome on the pharmacodynamics of heptabarbital: implications of severe hypoalbuminemia. J. Pharmacol Exp. Ther. 249:117\u2013122 (1989).","journal-title":"J. Pharmacol Exp. Ther."},{"key":"9054_CR16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0378-4347(94)00279-7","volume":"660","author":"D. B. Gomis","year":"1994","unstructured":"D. B. Gomis, V. J. Escotet Arias, L. E. Fidalgo Alvarez, and M. D. Gutierrez Alvarez. Simultaneous determination of vitamins D3, E and K1 and retinyl palmitate in cattle plasma by liquid chromatography with a narrow-bore column. J. Chromatogr. B Biomed. Appl. 660:49\u201355 (1994).","journal-title":"J. Chromatogr B Biomed. Appl"},{"key":"9054_CR17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jps.20039","volume":"93","author":"C. J. H. Porter","year":"2004","unstructured":"C. J. H. Porter, A. M. Kakunen, A. Taillardat-Bertschinger, B. J. Boyd, J. M. O'Connor, G. A. Edwards, and W. N. Charman. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J. Pharm Sci. 93:1110\u20131121 (2004).","journal-title":"J. Pharm Sci."},{"key":"9054_CR18","first-page":"97","volume":"292","author":"A. Bernard","year":"1981","unstructured":"A. Bernard, and H. Carlier. Intestinal lymphatic absorption of labelled oleic acid in the normal rat and rat treated with actidione-cycloheximide or acetoxycycloheximide. C R Seances Acad Sci. III 292:97\u2013100 (1981).","journal-title":"C R Seances Acad Sci. III"},{"key":"9054_CR19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.147.3662.1149","volume":"147","author":"S. M. Sabesin","year":"1965","unstructured":"S. M. Sabesin, and K. J. Isselbacher. Protein synthesis inhibition: mechanism for the production of impaired fat absorption. Science 147:1149\u201351 (1965).","journal-title":"Science"},{"key":"9054_CR20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/10837459609029889","volume":"1","author":"T. Gershanik","year":"1996","unstructured":"T. Gershanik, and S. Benita. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone. Pharm Dev. Technol. 1:147\u201357 (1996).","journal-title":"Pharm Dev. Technol"},{"key":"9054_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0169-409X(96)00489-9","volume":"25","author":"K. J. MacGregor","year":"1997","unstructured":"K. J. MacGregor, J. K. Embleton, J. E. Lacy, E. A. Perry, L. J. Solomon, H. Seager, and C. W. Pouton. Influence of lipolysis on drug absorption from the gastro-intestinal tract. Adv. Drug Deliv. Rev. 25:33\u201346 (1997).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9054_CR22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/bdd.2510110908","volume":"11","author":"I. Holmberg","year":"1990","unstructured":"I. Holmberg, L. Aksnes, T. Berlin, B. Lindback, J. Zemgals, and B. Lindeke. Absorption of a pharmacological dose of vitamin D3 from two different lipid vehicles in man: comparison of peanut oil and a medium chain triglyceride. Biopharm Drug Dispos 11:807\u2013815 (1990).","journal-title":"Biopharm Drug Dispos"},{"key":"9054_CR23","first-page":"65","volume-title":"Fat absorption, Vol. 2","author":"A. Kuksis","year":"1987","unstructured":"A. Kuksis. Absorption of fat soluble vitamins. In A. Kuksis (ed.), Fat absorption, Vol. 2, CRC, Boca Raton, 1987, pp. 65\u201386."},{"key":"9054_CR24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/jps.1110","volume":"90","author":"S. M. Khoo","year":"2001","unstructured":"S. M. Khoo, G. A. Edwards, C. J. H. Porter, and W. N. Charman. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine. J. Pharm Sci. 90:1599\u20131607 (2001).","journal-title":"J. Pharm Sci."},{"key":"9054_CR25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.2042-7158.1984.tb04919.x","volume":"36","author":"K. J. Palin","year":"1984","unstructured":"K. J. Palin, and C. G. Wilson. The effect of different oils on the absorption of probucol in the rat. J. Pharm Pharmacol 36:641\u20133 (1984).","journal-title":"J. Pharm Pharmacol"},{"key":"9054_CR26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1021\/js970300n","volume":"87","author":"D. J. Hauss","year":"1998","unstructured":"D. J. Hauss, S. E. Fogal, J. V. Ficorilli, C. A. Price, T. Roy, A. A. Jayaraj, and J. J. Keirns. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm Sci. 87:164\u2013169 (1998).","journal-title":"J. Pharm Sci."},{"key":"9054_CR27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V","volume":"89","author":"S. M. Caliph","year":"2000","unstructured":"S. M. Caliph, W. N. Charman, and C. J. Porter. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm Sci. 89:1073\u201384 (2000).","journal-title":"J. Pharm Sci."},{"key":"9054_CR28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejps.2005.07.011","volume":"26","author":"P. Gershkovich","year":"2005","unstructured":"P. Gershkovich, and A. Hoffman. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability. Eur. J. Pharm Sci. 26:394\u2013404 (2005).","journal-title":"Eur. J. Pharm Sci."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-006-9054-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-006-9054-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-006-9054-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T10:00:46Z","timestamp":1627725646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-006-9054-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,11]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["9054"],"URL":"https:\/\/doi.org\/10.1007\/s11095-006-9054-x","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,11]]}}}